Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hepatopoietin HPO2 | 0.0033 | 0.6156 | 0.6156 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1575 | 0.2581 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0033 | 0.6156 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0025 | 0.4142 | 0.4142 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0015 | 0.1575 | 0.1575 |
Plasmodium falciparum | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0033 | 0.6156 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0015 | 0.1575 | 0.2558 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1575 | 0.2581 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.1575 | 0.2558 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0033 | 0.6156 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.1575 | 0.2558 |
Trypanosoma cruzi | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0033 | 0.6156 | 0.5 |
Trypanosoma brucei | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0033 | 0.6156 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.1575 | 0.2558 |
Brugia malayi | Augmenter of liver regeneration | 0.0033 | 0.6156 | 0.6156 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.61 | 0.61 |
Leishmania major | hypothetical protein, conserved | 0.0033 | 0.6156 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1575 | 0.2581 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0033 | 0.6156 | 0.5 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0033 | 0.6156 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.61 | 1 |
Echinococcus granulosus | FAD linked sulfhydryl oxidase ALR | 0.0033 | 0.6156 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 1 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.1575 | 0.2558 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0009 | 0 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0025 | 0.4142 | 0.4142 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1575 | 0.1575 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0015 | 0.1575 | 0.1575 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 1 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0009 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.1575 | 0.2581 |
Echinococcus multilocularis | GPCR, family 2 | 0.0015 | 0.1575 | 0.2558 |
Plasmodium vivax | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0033 | 0.6156 | 0.5 |
Onchocerca volvulus | 0.0009 | 0 | 0.5 | |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.61 | 0.61 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0009 | 0 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0015 | 0.1575 | 0.1575 |
Echinococcus multilocularis | FAD linked sulfhydryl oxidase ALR | 0.0033 | 0.6156 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 73 nM | Agonist activity at glucocorticoid receptor in human A549 cells assessed as inhibition of PMA-induced AP-1 activation by luciferase reporter gene assay | ChEMBL. | 23953070 |
Efficacy (binding) | = 68 % | Agonist activity at glucocorticoid receptor in human A549 cells assessed as inhibition of PMA-induced AP-1 activation by luciferase reporter gene assay relative to dexamethasone | ChEMBL. | 23953070 |
Ki (binding) | = 11 nM | Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence polarization assay | ChEMBL. | 23953070 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.